
Global Nicotinamide Mononucleotide (NMN) Competitive Landscape Professional Research Report 2025
Description
Global Nicotinamide Mononucleotide (NMN) Competitive Landscape Professional Research Report 2025
Research Summary
Nicotinamide mononucleotide (NMN) is a molecule naturally found in the body and is a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for various biological processes. NMN is involved in cellular energy metabolism and plays a crucial role in maintaining cellular health and function. As we age, NAD+ levels in the body decline, which has been associated with various age-related health issues. NMN supplementation is believed to increase NAD+ levels, potentially offering benefits such as improved mitochondrial function, enhanced metabolism, and increased cellular repair. Research on NMN is ongoing, with studies exploring its potential effects on aging, longevity, and various age-related diseases. NMN supplements have gained popularity as a potential anti-aging intervention, although further research is needed to fully understand its effectiveness and safety.
According to DIResearch's in-depth investigation and research, the global Nicotinamide Mononucleotide (NMN) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Nicotinamide Mononucleotide (NMN). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nicotinamide Mononucleotide (NMN) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Nicotinamide Mononucleotide (NMN) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nicotinamide Mononucleotide (NMN) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Include:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Nicotinamide Mononucleotide (NMN) Product Segment Include:
Content Greater than or Equal to 98%
Content Less than 98%
Nicotinamide Mononucleotide (NMN) Product Application Include:
Health Care Products
Cosmetics
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Nicotinamide Mononucleotide (NMN) Capacity and Production Analysis
Chapter 3: Global Nicotinamide Mononucleotide (NMN) Industry PESTEL Analysis
Chapter 4: Global Nicotinamide Mononucleotide (NMN) Industry Porter's Five Forces Analysis
Chapter 5: Global Nicotinamide Mononucleotide (NMN) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 6: Global Nicotinamide Mononucleotide (NMN) Market Size and Forecast by Type and Application Analysis
Chapter 7: North America Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: Europe Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: China Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: APAC (Excl. China) Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Latin America Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Middle East and Africa Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 13: Global Nicotinamide Mononucleotide (NMN) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 16: Research Findings and Conclusion
Chapter 17: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Nicotinamide Mononucleotide (NMN) Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Nicotinamide Mononucleotide (NMN) Product by Type
- 1.2.1 Content Greater than or Equal to 98%
- 1.2.2 Content Less than 98%
- 1.3 Nicotinamide Mononucleotide (NMN) Product by Application
- 1.3.1 Health Care Products
- 1.3.2 Cosmetics
- 1.3.3 Others
- 1.4 Global Nicotinamide Mononucleotide (NMN) Market Revenue and Sales Analysis
- 1.4.1 Global Nicotinamide Mononucleotide (NMN) Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Nicotinamide Mononucleotide (NMN) Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Nicotinamide Mononucleotide (NMN) Market Sales Price Trend Analysis (2020-2032)
- 1.5 Nicotinamide Mononucleotide (NMN) Industry Trends and Innovation
- 1.5.1 Nicotinamide Mononucleotide (NMN) Industry Trends and Innovation
- 1.5.2 Nicotinamide Mononucleotide (NMN) Market Drivers and Challenges
- 2 Global Nicotinamide Mononucleotide (NMN) Capacity and Production Analysis
- 2.1 Global Nicotinamide Mononucleotide (NMN) Capacity, Production and Utilization (2020-2032)
- 2.2 Global Nicotinamide Mononucleotide (NMN) Production Growth Trend by Region: 2024 VS 2025 VS 2030
- 2.3 Global Nicotinamide Mononucleotide (NMN) Production by Region
- 2.3.1 Global Nicotinamide Mononucleotide (NMN) Production by Region (2020-2025)
- 2.3.2 Global Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2026-2032)
- 2.3.3 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2020-2032)
- 3 Nicotinamide Mononucleotide (NMN) Market PESTEL Analysis
- 3.1 Political Factors Analysis
- 3.2 Economic Factors Analysis
- 3.3 Social Factors Analysis
- 3.4 Technological Factors Analysis
- 3.5 Environmental Factors Analysis
- 3.6 Legal Factors Analysis
- 4 Nicotinamide Mononucleotide (NMN) Market Porter's Five Forces Analysis
- 4.1 Competitive Rivalry
- 4.2 Threat of New Entrants
- 4.3 Bargaining Power of Suppliers
- 4.4 Bargaining Power of Buyers
- 4.5 Threat of Substitutes
- 5 Global Nicotinamide Mononucleotide (NMN) Market Analysis by Regions
- 5.1 Nicotinamide Mononucleotide (NMN) Overall Market: 2024 VS 2025 VS 2032
- 5.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Forecast Analysis (2020-2032)
- 5.2.1 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Region (2020-2025)
- 5.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Forecast by Region (2026-2032)
- 5.3 Global Nicotinamide Mononucleotide (NMN) Sales and Forecast Analysis (2020-2032)
- 5.3.1 Global Nicotinamide Mononucleotide (NMN) Sales and Market Share by Region (2020-2025)
- 5.3.2 Global Nicotinamide Mononucleotide (NMN) Sales and Market Forecast by Region (2026-2032)
- 5.4 Global Nicotinamide Mononucleotide (NMN) Sales Price Trend Analysis (2020-2032)
- 6 Global Nicotinamide Mononucleotide (NMN) Market Size by Type and Application
- 6.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Type
- 6.1.1 Global Nicotinamide Mononucleotide (NMN) Revenue and Forecast Analysis by Type (2020-2032)
- 6.1.2 Global Nicotinamide Mononucleotide (NMN) Sales and Forecast Analysis by Type (2020-2032)
- 6.2 Global Nicotinamide Mononucleotide (NMN) Market Size by Application
- 6.2.1 Global Nicotinamide Mononucleotide (NMN) Revenue and Forecast Analysis by Application (2020-2032)
- 6.2.2 Global Nicotinamide Mononucleotide (NMN) Sales and Forecast Analysis by Application (2020-2032)
- 7 North America
- 7.1 North America Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate Analysis (2020-2032)
- 7.2 North America Key Manufacturers Analysis
- 7.3 North America Nicotinamide Mononucleotide (NMN) Market Size by Type
- 7.3.1 North America Nicotinamide Mononucleotide (NMN) Sales by Type (2020-2032)
- 7.3.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Type (2020-2032)
- 7.4 North America Nicotinamide Mononucleotide (NMN) Market Size by Application
- 7.4.1 North America Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2032)
- 7.4.2 North America Nicotinamide Mononucleotide (NMN) Revenue by Application (2020-2032)
- 7.5 North America Nicotinamide Mononucleotide (NMN) Market Size by Country
- 7.5.1 US
- 7.5.2 Canada
- 8 Europe
- 8.1 Europe Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate Analysis (2020-2032)
- 8.2 Europe Key Manufacturers Analysis
- 8.3 Europe Nicotinamide Mononucleotide (NMN) Market Size by Type
- 8.3.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2020-2032)
- 8.3.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Type (2020-2032)
- 8.4 Europe Nicotinamide Mononucleotide (NMN) Market Size by Application
- 8.4.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2032)
- 8.4.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Application (2020-2032)
- 8.5 Europe Nicotinamide Mononucleotide (NMN) Market Size by Country
- 8.5.1 Germany
- 8.5.2 France
- 8.5.3 United Kingdom
- 8.5.4 Italy
- 8.5.5 Spain
- 8.5.6 Benelux
- 9 China
- 9.1 China Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate Analysis (2020-2032)
- 9.2 China Key Manufacturers Analysis
- 9.3 China Nicotinamide Mononucleotide (NMN) Market Size by Type
- 9.3.1 China Nicotinamide Mononucleotide (NMN) Sales by Type (2020-2032)
- 9.3.2 China Nicotinamide Mononucleotide (NMN) Revenue by Type (2020-2032)
- 9.4 China Nicotinamide Mononucleotide (NMN) Market Size by Application
- 9.4.1 China Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2032)
- 9.4.2 China Nicotinamide Mononucleotide (NMN) Revenue by Application (2020-2032)
- 10 APAC (excl. China)
- 10.1 APAC (excl. China) Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate Analysis (2020-2032)
- 10.2 APAC (excl. China) Key Manufacturers Analysis
- 10.3 APAC (excl. China) Nicotinamide Mononucleotide (NMN) Market Size by Type
- 10.3.1 APAC (excl. China) Nicotinamide Mononucleotide (NMN) Sales by Type (2020-2032)
- 10.3.2 APAC (excl. China) Nicotinamide Mononucleotide (NMN) Revenue by Type (2020-2032)
- 10.4 APAC (excl. China) Nicotinamide Mononucleotide (NMN) Market Size by Application
- 10.4.1 APAC (excl. China) Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2032)
- 10.4.2 APAC (excl. China) Nicotinamide Mononucleotide (NMN) Revenue by Application (2020-2032)
- 10.5 APAC (excl. China) Nicotinamide Mononucleotide (NMN) Market Size by Country
- 10.5.1 Japan
- 10.5.2 South Korea
- 10.5.3 India
- 10.5.4 Australia
- 10.5.5 Southeast Asia
- 11 Latin America
- 11.1 Latin America Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Latin America Key Manufacturers Analysis
- 1`.3 Latin America Nicotinamide Mononucleotide (NMN) Market Size by Type
- 11.3.1 Latin America Nicotinamide Mononucleotide (NMN) Sales by Type (2020-2032)
- 11.3.2 Latin America Nicotinamide Mononucleotide (NMN) Revenue by Type (2020-2032)
- 11.4 Latin America Nicotinamide Mononucleotide (NMN) Market Size by Application
- 11.4.1 Latin America Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2032)
- 11.4.2 Latin America Nicotinamide Mononucleotide (NMN) Revenue by Application (2020-2032)
- 11.5 Latin America Nicotinamide Mononucleotide (NMN) Market Size by Country
- 11.6 Latin America Nicotinamide Mononucleotide (NMN) Market Size by Country
- 11.6.1 Mexico
- 11.6.2 Brazil
- 12 Middle East & Africa
- 12.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate Analysis (2020-2032)
- 12.2 Middle East & Africa Key Manufacturers Analysis
- 12.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market Size by Type
- 12.3.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Type (2020-2032)
- 12.3.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Type (2020-2032)
- 12.4 Middle East & Africa Nicotinamide Mononucleotide (NMN) Market Size by Application
- 12.4.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2032)
- 12.4.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Application (2020-2032)
- 12.5 Middle East Nicotinamide Mononucleotide (NMN) Market Size by Country
- 12.5.1 Saudi Arabia
- 12.5.2 South Africa
- 13 Competition by Manufacturers
- 13.1 Global Nicotinamide Mononucleotide (NMN) Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 13.1.1 Global Nicotinamide Mononucleotide (NMN) Market Sales by Key Manufacturers (2021-2025)
- 13.1.2 Global Nicotinamide Mononucleotide (NMN) Market Revenue by Key Manufacturers (2021-2025)
- 13.1.3 Global Nicotinamide Mononucleotide (NMN) Average Sales Price by Manufacturers (2021-2025)
- 13.2 Nicotinamide Mononucleotide (NMN) Competitive Landscape Analysis and Market Dynamic
- 13.2.1 Nicotinamide Mononucleotide (NMN) Competitive Landscape Analysis
- 13.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 13.2.3 Market Dynamic
- 14 Key Companies Analysis
- 14.1 GeneHarbor
- 14.1.1 GeneHarbor Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.1.2 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolio
- 14.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.2 Herbalmax
- 14.2.1 Herbalmax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.2.2 Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolio
- 14.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.3 Genex Formulas
- 14.3.1 Genex Formulas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.3.2 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
- 14.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.4 Shinkowa Pharmaceutical
- 14.4.1 Shinkowa Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.4.2 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Product Portfolio
- 14.4.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide (NMN) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.5 Maac10 Formulas
- 14.5.1 Maac10 Formulas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.5.2 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
- 14.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.6 EffePharm
- 14.6.1 EffePharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.6.2 EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolio
- 14.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.7 Bontac
- 14.7.1 Bontac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.7.2 Bontac Nicotinamide Mononucleotide (NMN) Product Portfolio
- 14.7.3 Bontac Nicotinamide Mononucleotide (NMN) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.8 CELFULL
- 14.8.1 CELFULL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.8.2 CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolio
- 14.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14.9 Kingdomway
- 14.9.1 Kingdomway Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 14.9.2 Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolio
- 14.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 15 Industry Chain Analysis
- 15.1 Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
- 15.2 Nicotinamide Mononucleotide (NMN) Industry Raw Material and Suppliers Analysis
- 15.2.1 Nicotinamide Mononucleotide (NMN) Key Raw Material Supply Analysis
- 15.2.2 Raw Material Suppliers and Contact Information
- 15.3 Nicotinamide Mononucleotide (NMN) Typical Downstream Customers
- 15.4 Nicotinamide Mononucleotide (NMN) Sales Channel Analysis
- 16 Research Findings and Conclusion
- 17 Methodology and Data Source
- 17.1 Methodology/Research Approach
- 17.2 Research Scope
- 17.3 Benchmarks and Assumptions
- 17.4 Date Source
- 17.4.1 Primary Sources
- 17.4.2 Secondary Sources
- 17.5 Data Cross Validation
- 17.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.